Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study on the Accurate Evaluation of Pseudoprogression of Rectal Cancer Immunotherapy Based on Multitemporal and Multiparameter MRI

NCT07381322 is registered in ClinicalTrials.gov with Peiyi Xie as lead sponsor.

NCT NCT07381322
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07381322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study on the Accurate Evaluation of Pseudoprogression of Rectal Cancer Immunotherapy Based on Multitemporal and Multiparameter MRI
Lead sponsor
Peiyi Xie
Phase
Observational
Overall status
Recruiting
Start date
February 1, 2026
Completion date
December 31, 2029
Enrollment
300 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer